• EZH2 Inhibition in HPV-Associated Cervical Cancer

  2026-08-19

  The reference study evaluates EPZ6438 and ZLD1039 as EZH2 inhibitors in HPV-positive and HPV-negative cervical cancer models, combining proliferation, cell-cycle, apoptosis, molecular, and preliminary chorioallantoic membrane readouts. Its main contribution is evidence that EZH2 inhibition, particularly with EPZ6438, may be more effective in HPV-positive cells than cisplatin across several cellular and mechanistic endpoints.

• Vorinostat: Cell Death Beyond Transcription

  2026-08-18

  Vorinostat, also called suberoylanilide hydroxamic acid, is an HDAC inhibitor that connects chromatin remodeling with intrinsic apoptosis. This guide uses recent RNA polymerase II biology to show how researchers can distinguish transcriptional suppression, cytostasis, and genuine cell death in oncology assays.

• Ribonuclease R for Circular RNA Workflows

  2026-08-18

  Build cleaner circular RNA enrichment, validation, and sequencing workflows with a processive enzyme that removes linear RNA while preserving many circular and structured species. This guide translates findings from a pulpitis study into practical assay design, controls, optimization steps, and troubleshooting strategies.

• Recombinant Mouse IFN-γ for Antigen Presentation

  2026-08-17

  Recombinant Mouse IFN-γ is a research-grade Interferon gamma preparation for murine antiviral, immunomodulatory, macrophage, TH1, and antigen-presentation workflows. Product benchmarks include greater than 95% SDS-PAGE purity, endotoxin below 1 EU/µg, and an antiviral-assay EC50 of 0.3–0.9 ng/mL under the stated L-929 and encephalomyocarditis virus conditions.

• BRD4–RAC1 Co-targeting in Breast Cancer

  2026-08-17

  The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-sensitive strategy that suppresses breast cancer growth, migration, stemness, and tumorigenesis. Its mechanistic contribution is the connection of BRD4–RAC1 signaling to the c-MYC–G9a–FTH1 axis and HDAC1-associated histone regulation, providing a framework for testing epigenetic dependencies in cancer models.

• ETV5, EZH2, and Hepatocellular Carcinoma Progression

  2026-08-16

  This pan-cancer study identifies ETV5 as a prognostic transcription factor linked to epigenetic regulation and demonstrates a functional relationship between ETV5, EZH2 activity, and hepatocellular carcinoma progression. Its integrated computational and experimental design suggests that ETV5 may help explain adverse prognosis and reduced response to the EZH2 inhibitor GSK126 in selected tumors.

• SAR405: A Precision Vps34 Inhibitor Workflow

  2026-08-15

  SAR405 provides a selective way to separate Vps34-dependent phosphatidylinositol 3-phosphate production from upstream energy-stress signaling. This practical workflow combines dose finding, GFP-FYVE or GFP-LC3 imaging, lysosome readouts, and AMPK–ULK1-aware controls for autophagy inhibition, vesicle trafficking modulation, and cancer research.

• Chuanxiong Cortex, Pith, and CHD Mechanisms

  2026-08-14

  The reference study combines SPME-GC×GC-MS, network pharmacology, and molecular docking to distinguish the volatile chemical and predicted therapeutic profiles of Chuanxiong cortex and pith in coronary heart disease research. Its main contribution is to show that anatomically distinct rhizome regions should not be treated as chemically interchangeable, while also providing a hypothesis-generating workflow for prioritizing compounds and targets.

• EZH2 Inhibition in HPV-Associated Cervical Cancer

  2026-08-14

  The reference study evaluates EPZ-6438 and ZLD1039 as EZH2 inhibitors in HPV-positive and HPV-negative cervical cancer models, combining proliferation, apoptosis, cell-cycle, molecular, and exploratory in vivo readouts. Its main contribution is the identification of stronger EPZ-6438 activity in HPV-positive cells and the association of EZH2 inhibition with reduced HPV16 E6/E7 expression, restoration of p53 and Rb, and epithelial-state markers.

• Caspase 3/7 Link Autophagy to DNA Damage Responses

  2026-08-13

  The reference study identifies CASP3 and CASP7 as active regulators of cytoprotective autophagy and DNA damage signaling during non-lethal stress in human breast cancer cells. Its genetic, biochemical, and rescue experiments show that caspase activity can support stress adaptation rather than simply execute apoptosis, while revealing synthetic lethality with BRCA1 loss.

• Tubastatin A: HDAC6 Inhibitor Workflow Guide

  2026-08-13

  Build more informative HDAC6 inhibition experiments with Tubastatin A, from DMSO stock preparation and target-engagement assays to cell-death pathway profiling. A porcine cardiac-arrest study adds a practical translational model for connecting microtubule regulation with pyroptosis, necroptosis, and myocardial injury.

• M344: Reliable HDAC Assay Workflows

  2026-08-12

  This scenario-driven guide explains how M344 (SKU A4105) can improve experimental planning for viability, proliferation, cytotoxicity, apoptosis, and differentiation studies. It connects documented potency, cell-model evidence, formulation guidance, and vendor-selection criteria to practical laboratory decisions.

• AZ505: A Translational Framework for SMYD2 Inhibition

  2026-08-12

  A mechanistic and translational guide to using AZ505, a potent and selective SMYD2 inhibitor, across epigenetic regulation research, cancer biology, and fibrosis models.

• SP2509 Workflows for LSD1-Targeted AML Research

  2026-08-11

  SP2509 combines potent LSD1 inhibition with a practical workflow for studying histone-state changes, apoptosis induction in AML cells, and differentiation-associated phenotypes. This guide connects biochemical validation, chromatin assays, combination studies, and troubleshooting while keeping evidence from acute myeloid leukemia models distinct from hypothesis-generating breast cancer research.

• Rocilinostat (ACY-1215) Experimental Workflow Guide

  2026-08-11

  Rocilinostat (ACY-1215) enables selective HDAC6 interrogation in multiple myeloma viability, apoptosis, and proteasome-inhibitor combination assays. This workflow also shows how its acetylated α-tubulin readout can support carefully controlled, hypothesis-generating studies of primary cilia and neural progenitor biology.

7969 records 3/532 page Previous Next 12345 下5页 Last page